Digital Content 
NEWS #PharmaBuzz
01 Sep 2021
// ESCARDIO
https://www.escardio.org/The-ESC/Press-Office/Press-releases/Edoxaban-noninferior-to-warfarin-for-adverse-events-after-heart-valve-replacement
10 Nov 2020
// EUREKALERT
https://www.eurekalert.org/pub_releases/2020-11/acor-wus110520.php#:~:text=ATLANTA%20%2D%2D%20New%20research%20presented,patients%20with%20osteoarthritis%20(ABSTRACT%20%230934
16 Mar 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/portola-pharmaceuticals-announces-results-demonstrating-andexxa-was-associated-with-lowest-rate-of-mortality-in-patients-with-multiple-types-of-factor-xa-inhibitor-related-bleeds-301024484.html
18 Mar 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/xarelto-rivaroxaban-significantly-reduced-the-risk-of-overall-strokes-and-the-most-severe-strokes-and-was-associated-with-fewer-stroke-related-deaths-in-the-real-world-versus-warfarin-in-patients-with-nonvalvular-atrial-fibrill-300813853.html
06 Dec 2018
// Jonas Söderström ENDPTS
https://endpts.com/cereno-scientific-is-driving-a-new-paradigm-of-thrombosis-prevention-without-associated-bleeding-risks/
25 Sep 2018
// Lisa Rapaport REUTERS
https://www.reuters.com/article/us-health-afib-stroke/increased-use-of-anti-clotting-drugs-tied-to-fewer-strokes-in-patients-with-atrial-fibrillation-idUSKCN1M42HY?feedType=RSS&feedName=healthNews
LOOKING FOR A SUPPLIER?
Share